About FARSIGHT GENOME SYSTEMS, INC.
Farsight Genome Systems developed Farsight Correo, a clinical-grade, cloud-based platform for genomic data management and analysis with the mission to make next-generation sequencing (NGS) tests and precision medicine programs more accessible, scalable, cost-effective, and administratively feasible. Farsight Correo delivers fully-automated genomic data analytic performance that is vendor-agnostic , making it a turn-key, cost-effective solution for molecular laboratories and healthcare institutions regardless of their existing IT infrastructure.
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to FARSIGHT GENOME SYSTEMS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.